A case of recurrent cutaneous eosinophilic vasculitis: Successful adjuvant therapy with suplatast tosilate [11]

British Journal of Dermatology

Volumn 149, Issue 4, 2003, Pages 901-903

  Sakuma Oyama, Y ^a   Nishibu, A ^b   Oyama, N ^a   Saito, M ^b   Nakamura, K ^b   Kaneko, F ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IPD; PREDNISOLONE; SUPLATAST TOSYLATE;

ADULT; BLOOD VESSEL INJURY; CASE REPORT; CLINICAL FEATURE; CUTANEOUS EOSINOPHILIC VASCULITIS; DISEASE COURSE; DOSE RESPONSE; EOSINOPHILIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LABORATORY TEST; LETTER; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; SKIN BIOPSY; TREATMENT PLANNING; VASCULITIS;

ADULT; ANTI-ALLERGIC AGENTS; ARYLSULFONATES; DRUG THERAPY, COMBINATION; EOSINOPHILIA; FEMALE; HUMANS; RECURRENCE; SKIN DISEASES, VASCULAR; SULFONIUM COMPOUNDS; VASCULITIS;

EID: 0242467300     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05568.x     Document Type: Letter

References (8)

1. Chen K, Pittelkow MR, Su WPD et al. Recurrent cutaneous eosinophilic necrotizing vasculitis. A novel eosinophil-mediated syndrome. Arch Dermatol 1994; 130: 1159-66.
2. Launay D, Delaporte E, Gillot JM et al. An unusual cause of vascular purpura: recurrent cutaneous eosinophilic necrotizing vasculitis. Acta Derm Venereal (Stockh) 2000; 80: 394-5.
3. Tamaoki J, Kondo M, Sakai N et al. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-bind randomised study. Lancet 2000; 356: 273-8.
4. Oda N, Minoguchi K, Yokoe T et al. Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell lines. Life Sci 1999; 65: 763-70.
5. Dobrina A, Menegazzi R, Carlos TM et al. Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced endothelial ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor. J Clin Invest 1991; 88: 20-6.
6. Perez-Lorenzo R, Zambrano-Zaragoza JF, Saul A et al. Autoantibodies to autologous skin in guttate and plaque forms of psoriasis and cross-reaction of skin antigens with streptococca] antigens. Int J Dermatol 1998; 37: 524-31.
7. Kaneko F, Oyama N, Nishibu A. Streptococcal infection in the pathogenesis of Behçet's disease and clinical effect of minocycline on the disease symptoms. Yonsei Med J 1997; 38: 444-54.
8. Tojo M, Yanagihori H, Zheng X et al. Detection of microbial DNA in skin lesions from patients with Behçet's disease. Adv Exp Med Biol 2003; 528: 185-90.